Home Cart Sign in  
Chemical Structure| 1956356-56-1 Chemical Structure| 1956356-56-1

Structure of KYA1797K
CAS No.: 1956356-56-1

Chemical Structure| 1956356-56-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

KYA1797K serves as a potent and selective inhibitor of the Wnt/β-catenin pathway, with an IC50 of 0.75 µM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of KYA1797K

CAS No. :1956356-56-1
Formula : C17H11KN2O6S2
M.W : 442.51
SMILES Code : O=C([O-])CCN(C/1=O)C(SC1=C\C2=CC=C(C3=CC=C([N+]([O-])=O)C=C3)O2)=S.[K+]
MDL No. :MFCD30718585
InChI Key :PHUNRLYHXGMOLG-WQRRWHLMSA-M
Pubchem ID :119057297

Safety of KYA1797K

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
TNBC cells 5 or 25 µM 24 h KYA1797K downregulates β-catenin, RAS, and EGFR and suppresses proliferation and colony formation. PMC7272395
CRC cells 25 μM 3 to 7 days effectively suppressed the stemness of CSCs PMC7060567

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice TNBC PDX tumors Intraperitoneal injection 25 mg/ml daily until tumor size reached between 150 and 200 mm3 KYA1797K suppressed the growth of TNBC PDX tumors. PMC7272395
Mice ApcMin/+ /KrasG12DLA2 mice Intraperitoneal injection 25 mg/kg 5 days per week for 7 weeks suppressed tumor growth and reduced stemness of CSCs PMC7060567
Athymic nu/nu mice tumor xenograft model Intraperitoneal injection 20 mg/kg once daily for 21 days To test the effect of KYA1797K on tumor growth, results showed that KYA1797K significantly reduced tumor volume and weight. PMC6244225

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.26mL

0.45mL

0.23mL

11.30mL

2.26mL

1.13mL

22.60mL

4.52mL

2.26mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories